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Abstract 
 
Background: Diabetes mellitus (DM) represents a continuously growing worldwide threat with major financial 
impact on the healthcare systems. The importance of tight glycaemic control in patients with DM type II is well 
established and is most effectively accomplished with the proper cooperation of both the treating physicians as 
well as the treated subjects.  
Aims: The aim of our study was to evaluate the level of awareness of patients with DM type II about the various 
aspects of DM, including the nature of the disease, its precipitating factors and complications, as well as its 
treatment.                                                                                 
Methodology: The patients were asked to complete anonymously a questionnaire concerning their knowledge 
about diabetes, its basic pathophysiology and complications, the treatment options and possible side-effects.                                                                                                    
Data were analyzed using STATA statistical software (Version 9.0). 
Results: Eighty patients were on oral hypoglycaemic agents (OHA), 34 on insulin while 4 were under a hybrid 
treatment. Among patients on OHA, 40 patients (50%) were taking a combination of them. 13,4% of the sample 
was aware of what DM stands for, 84,9% did not know the type of DM they were suffering from, while  (85,7%) 
considered that obesity plays a major role in the pathogenesis of DM. Concerning the therapy of DM, only 
54,83% of the patients were aware of the brand names of their antidiabetic medication, 88,2% did not know their 
way of action, while  60,5% did not know the possible side effects. The majority of the sample, 60,5%, assumed 
that blood glucose should be measured only before meals. 
Conclusions: The knowledge of the subjects visiting the center for the first time was found to be inadequate. 
This is probably due to inadequate information, non-availability of educational material and improper guidance.  
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Introduction 
 
Diabetes mellitus (DM) represents a continuously 
growing  worldwide  threat  with  major  financial 
impact on the healthcare systems. The importance 
of  tight  glycaemic  control  in  patients  with  DM 
type II is well established and is most effectively 
accomplished with the proper cooperation of both 
the  treating  physicians  as  well  as  the  treated 
subjects (Caballero, 2009). Besides diet, exercise, 
oral  hypoglycemic  agents  and  insulin  are  the 
cornerstone  of  DM  treatment  and  when  taken 
appropriately,  seem  to  be  acceptably  effective 
(Pappas  and  Karaoulli,  2010,  Barnes  and  Hong 
2012).  
Unfortunately,  patient  compliance  with  the 
prescribed treatment is often sub-optimal, which 
may  have  a  deleterious  effect  on  glycaemic 
control.  Poor  compliance  may  be  attributed  to 
various reasons: incomplete patient understanding 
of the nature of their disease, of the importance of 
taking their hypoglycemic agents as prescribed, of 
their  actions  or  side-effects  or  finally  of  the 
possible complications of DM. In the same lines, 
the  information  provided  to  patients  by  their 
physicians may be rather quite obscure or simply 
not  elaborate  enough  to  be  satisfactorily 
understood  (Calle-Pascual  et  al,  2002, 
Konstantikaki  2008,  Cederholm  et  al,  2009, 
Krepia et al,  2011).  
The aim of our study was to evaluate the level of 
awareness of patients with DM type II about the 
various aspects of DM including the nature of the 
disease,  its  precipitating  factors  and 
complications, as well as its treatment. Moreover, 
we  assessed  their  knowledge  concerning  the 
medication  they  received,  their  action,  correct 
dosing, side-effects and proper follow-up. 
 
Methodology 
 
The study population consisted of 119 consecutive 
patients (57 male, 62 women, mean age 68+/-13 
years  old,  duration  of  DM  6.1  years)  with  DM 
type II who attended the outpatient diabetic clinic 
of our institution. All subjects underwent the usual 
clinical  and  laboratory  evaluation.  Diabetes  was 
defined according to ADA criteria. The presence 
and  severity  of  hypertension  were  determined 
according to the JNC VI guidelines. History of CV 
and other diseases was defined as a self-reported 
history  or  written  information  from  the  medical 
records.  
Anthropometric  determinations  such  as  weight 
and height were measured by standard techniques, 
and  body  mass  index  (BMI)  was  calculated  as 
body  weight  in  kilograms  divided  by  height  in 
meters squared.  
Waist  circumference  was  measured  at  the 
midpoint between the low rib margin and the iliac 
bone, and hip circumference was measured at the 
trochanter  level.  Both  circumferences  were 
measured to the nearest 0.5 cm and ratio between 
them provided the waist/hip ratio. 
The patients were asked to complete anonymously 
a questionnaire concerning their knowledge about 
diabetes,  its  basic  pathophysiology  and 
complications, the treatment options and possible 
side-effects. 
 
Statistical analysis 
 
Data  were  analyzed  using  STATA  statistical 
software (Version 9.0, Stata Corporation, College 
Station,  TX  77845,  USA).The  normality  of  the 
distribution of the continuous variables was tested 
by using the Shapiro-Wilk statistic. All variables 
had normal distribution.  
In  order  to  assess  any  differences  between  the 
groups for various categories, the Student’s t-test 
was  used  for  the  continuous  variables  after 
controlling  for  equality  of  variances.  The 
frequencies of the categorical variables are shown 
in  contingency  tables,  while  the  Pearson’s  chi-
square statistic was used in order to assess for any 
correlation. All categorical variables are presented 
as absolute frequencies and percentages, while the 
continuous  variables  are  shown  as  means  and 
standard  deviations.  The  potential  effect  of  the 
independent variables on the outcome (dependent 
variable) was tested using univariate and multiple 
logistic  regression  models.  In  addition,  log-
binomial  models  were  calculated  in  order  to 
produce  relative  risks  rather  than  odds  ratios, 
making the results of this study comparable with 
modern literature. All reported p-values are based 
on two-sided tests and compared to a significance 
level of 5%.  
 
Results 
 
The study population consisted of 119 consecutive 
patients (57 male, 62 women, mean age 68+/- 13.1 
years  old),  115  with  DMII  and  4  with  DMI. 
Demographic,  anthropometric,  clinical  and 
metabolic  determinations,  as  well  as 
echocardiographic examination data of the base-
line  examination  of  the  whole  population  are 
presented in Table 1. 
Eighty  patients  were  on  oral  hypoglycaemic 
agents (OHA), 34 on insulin while 4 were under a 
hybridic treatment. Among patients on OHA, 40  
patients (50%) were taking a combination of them.  
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Table 1. Base-line demographic, clinical and  
laboratory data of the study population. 
 Data presented as mean ± standard deviation (SD)  
 
Characteristic/Parameters  Data  
Age (years)  68,2 ± 13,1 
Male (%)  57 (47,9%) 
Type of DM (I/II)  4 (3,4%) / 115 
(94,6%) 
BMI (kg/m
2)  28.53±4.66 
Waist circum ference  
(cm) 
96.65±22.73 
Duration of hypertension  
(years) 
6.06±7.38 
Smoking currently (%)  29.4 
Previous treatment (%)  65.0 
DM (%)  9.1 
Office SBP (mmHg)    147.25±20.20 
Office DBP (mmHg)   93.38±11.87 
Office PP (mmHg)  53.87±16.98  
Heart rate (bpm)  72.69±10.23  
Previous CAD (%)  4.8 
Previous stroke (%)  2.3 
Serum glucose (mg/dl)  100.38±28.08 
Serum creatinine (mg/dl)  0.98±0.59 
Total cholesterol (mg/dl)  228.05±66.31 
LDL cholesterol (mg/dl)  129.78±87.33 
HDL cholesterol (mg/dl)  52.23±18.77 
Serum triglycerides 
(mg/dl) 
148.40±39.83 
SUA (mg/dl)  5.50±5.75 
BMI: body mass index, CAD: coronary artery 
disease, DM: diabetes mellitus 
 
In details, 69 took sulphonylureas, 48 metformin, 
9  thiazolidinediones,  while  among  the  patients 
taking  more  than  one  OHA,  the  most  common 
combination  was  sulphonylurea  plus  metformin 
(35 patients, 87%) (Table 2). 
It is worth-noting that only 56.8% of the whole 
population was taking their medication in a correct 
way (Table 3). 
Concerning  the  questions  about  DM,  only  16 
patients (13.4%) were aware of what DM is, 101 
(84,9%) did not know the type of DM they were 
suffering from, while 102 (85,7%) considered that 
obesity plays a major role in the pathogenesis of 
DM.To  the  question  which  organ  affect  DMII  , 
91,6% responded the eyes, 55,5% the heart, 47,9% 
the lower extremities, 37% the kidneys, 23,5% the 
arteries  and  10,1%  all  the  body  tissues. 
Concerning the therapy of DM, only 57 patients 
(48,3%) were aware of the brand names of their 
antidiabetic medication, 105 (88,2%) did not know 
their  way  of  action,  while  72  patients           
(60,5%) did not know the possible side effects.  
 
Table 2. Antidiabetic treatment 
of our study population 
 
Type of treatment  Patients  
(n=119) 
OHA (n,%)  80 (67,8%) 
Insulin  34 (28,8%) 
Insulin + OHA  4 (3,4%) 
   
Monotherapy  75 (63%) 
Drug combination  44 (37%) 
   
Sulphonylureas  69 
Metformin  48 
Thiazolidinediones  9 
Sulphonylureas  + 
Metformin 
35 
 
OHA: oral hypoglycaemic agents 
 
 
Table 3. Percentage of patients with 
correct use of their medication 
 
Antidiabetic agent  Correct use of medication 
Insulin  92,1% 
Sulphonylureas  61% 
Metformin  58,3% 
Thiazolidinediones  33,3% 
Sulphonylureas  + 
Metformin 
54,2% 
 
 
Concerning the question about the self-control of 
DM,  17  patients  (14,  3%)  were  aware  of  the 
importance  of  the  HbA1c.  77,  3%  (92  patients) 
had blood glucose testing meter and 89, 1% (106 
patients) did not know the importance of the daily 
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The  majority  (72  patients,  60,5%)  assumed  that 
blood  glucose  should  be  measured  only  before 
meals  while  46  patients  (38,7%)  did  measure 
blood glucose before and after meals. 15% of the 
patients  measured  blood  glucose  only  once  per 
week or less, 33% daily, 30% 2-3 times per day 
16,8% more than 3 per day(Table 4). 
Concerning the questions about the follow up of 
DM, 22% of the patients responded that only once 
or twice per year should visit the physician, 37% 
monthly while 17, 6% was not aware of the follow 
up. 47, 5% of the patients did not know about the 
ophthalmological  follow  up,  while  35,  3%  had 
never a test-eye examination (Table 5).     
Comparing the general knowledge of DM between 
the two sexes, we found out that men were better 
informed about DM (21,1% vs 6,5%, p<0,05), the 
OHA  (57,1%  vs  40,3%  ,  p<0,05)  and  the 
importance  of  HbA1c  (21,1%  vs  8,1%,  p<0,05) 
than women. 
Insulin  treated  patients  with  DM  type  II  were 
better  informed  about  the  correct  use  of  their 
antidiabetic  medication  (84,2%  vs  43,8%, 
p<0,0001), their way of action (28,9% vs 3,8%, 
p<0,001) and their possible side effects (60,5% vs 
28,8%, p<0,001) than tablets treated patients.  
Finally,  the  age  of  the  diabetic  patients  was 
inversely correlated to the knowledge of DM and 
each medication (Table 6).  
 
Table 4. Patient knowledge about the control of DM 
 
  Patients 
(n=119) 
  YES      NO
Do you know HbA1c is?  14,3%  85,7% 
Do  you  have  blood  glucose 
testing meter at home? 
77,3%  22,7% 
Do  you  need  to  measure 
blood glucose at home? 
89,1%  10,9% 
   
Before 
meals 
60,5%  When 
should  you 
measure 
blood 
glucose? 
Before  and 
after meals 
39,5% 
   
Never  5,2% 
1  or  less  / 
per week 
15% 
1 /  per day  33% 
2-3 / per day  30% 
How  often 
should  you 
measure 
blood 
glucose  at 
home? 
>3 / per day  16,8% 
 
 
Discussion 
 
The  management  of  Diabetes  Mellitus  not  only 
requires  the  prescription  of  the  appropriate 
nutritional  and  pharmacological  regimen  by  the 
physician  but  also  intensive  education  and 
counseling of the patient (Cederholm et al,2005, 
Derson et al,1994).  
The control of obesity and the ideal body weight is 
important  for  better  glycemic  control  and 
prevention of complications but the characteristics 
of our patients were not according to this norm as 
more than half of the patients were overweight or 
obese  (Gikas  et  al,2008)  .  The  majority  of  the 
patients  had  a  wrong  assessment  of  their  own 
weight  and  most  overweight  patients  did  not 
consider  themselves  to  be  overweight,  thus  a 
problem with their attitudes (Rekleiti et al,2008).  
 
 
Table 5. Patient knowledge about the follow up of 
DM 
 
  Patients(n=119) 
Never  1,7% 
1-2 / per 
year 
22,7% 
3-6  per 
year 
21% 
Monthly  37% 
How  often 
should  you  visit 
your 
diabetologist? 
Don’t 
know 
17,6% 
   
Never  1,7% 
1-2 / per 
year 
43,6% 
3-6  per 
year 
5,9% 
Monthly  1,7% 
How  often 
should  you  visit 
your 
ophthalmologist? 
Don’t 
know 
47,1% 
   
Never  35,4% 
Last 
year 
21,8% 
2-3 
years 
ago 
33,6% 
When  did  you 
have  your  last 
test-eye 
examination? 
>  3 
years 
ago 
9,2% 
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The  results  of  this  study  highlights  the  need  to 
educate  the  patients  about  their  body  weight  as 
well as assessment of obesity (Chao et al, 2008, 
Charpentier et al, 2003).  
 
Table 6. Age and Self evaluation of DM   
 
  AGE   
  YES  NO  p 
value 
Do  you  know  what 
DM is? 
59,2 ± 
8,7 
69,6 
± 9,2 
<0,05 
     
What  type  of  DM 
do you have? 
58 ± 
10,2 
69,9 
± 8,4 
<0,01 
      
Do  you  know  the 
brand  names  of 
your  DM 
medication? 
63,9 ± 
9,4 
72,1 
± 7,8 
<0,01 
     
Do  you  know  their 
way of action? 
59 ± 
10,4 
69,4 
± 9,5 
<0,05 
     
Do  you  know  what 
HbA1c is? 
61,5 ± 
11,4 
69,3 
± 
10,3 
<0,05 
     
Correct  use  of 
medication 
61,5 ± 
9,9 
72,1 
± 9,1 
<0,05 
 
Greater  BMI  with  co-relation  to  poor  glycemic 
control was comparative in females only. It was 
not easy for everyone to understand the concept of 
Body Mass Index and it was suggested that waist 
circumference may be used as a crude parameter 
instead  as  it  is  easier  and  more  understandable 
(Rekliti , et al, 2010) . Glycemic control could be 
improved  by  a  weight  loss  of  only  10%  of  the 
initial  weight  and  thus  public  education  and 
awareness  about  the  beneficial  effects  of 
consuming  a  healthy  diet  is  required.  Self-
monitoring  of  blood  glucose  is  a  simple  and 
practical  procedure  acceptable  for  those  patients 
who can afford it and facilitates the attainment of 
good  glycemic  control  but  unfortunately  in  our 
local population the practice of using glucometers 
was not good, as although 77,3% of the patients 
had  their  own  glucometers,  only  33%  measured 
blood glucose once per day (Culhane-Pera et al, 
2005).  The  overall  awareness  about  the  risk  of 
complications  was  satisfactory  but  the 
misconceptions regarding glucose control, insulin 
and diabetes were quite common (Kyriazis et al, 
2010, Mytas et al, 2009). 
The knowledge of the subjects visiting the center 
for the first time was found to be inadequate. This 
probably  is  due  to  inadequate  information,  non-
availability of educational material and improper 
guidance. The reasons of the poor knowledge need 
to be further studied in detail in our population.  
There is need for arranging large scale awareness 
programs  for  the  general  public  and  also  to 
identify  and  use  media  to  spread  the  message 
which could change the attitude of our public in 
the future (Dinsmoor,2006). 
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